cancer-therapy

Documents about cancer-therapy

• Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer#181751ClinicalTrials.gov
• A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer#140988ClinicalTrials.gov
• Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer#201769ClinicalTrials.gov
• A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer#283035ClinicalTrials.gov
• Supplementary file 1_Adverse events associated with targeted therapy and immunotherapy for ovarian cancer: a FAERS pharmacovigilance study.docx#300638Figshare
• Post-therapeutic support and rehabilitation for breast cancer women in complete remission in a thermal resort: study protocol for the PACThe Real-Life conditions observational trial#124635HAL (France)
• Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer#158219ClinicalTrials.gov
• Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy#249605ClinicalTrials.gov
• Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer#481756ClinicalTrials.gov
• Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer#623527ClinicalTrials.gov
• Rapid Modulation of Circulating Adipokines and Inflammatory Cytokines in Localized Prostate Cancer Following Short-Term Leuprolide Therapy.#9139NCBI PubMed Central
• Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease#121366ClinicalTrials.gov
• Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT#123480ClinicalTrials.gov
• Nominal plan robustness may predict plan degradation in proton therapy for oropharyngeal head-and-neck cancer.#151465NCBI PubMed Central
• Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer#154673ClinicalTrials.gov
• DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection#154726ClinicalTrials.gov
• Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC#160370ClinicalTrials.gov
• Integrative analysis of tumor-educated platelets for stage-specific diagnosis, prognosis, and therapy in ovarian cancer.#170586NCBI PubMed Central
• Variation of the relative biological effectiveness with fractionation in proton therapy: analysis of prostate cancer response#176467arXiv Biology
• Variation of the relative biological effectiveness with fractionation in proton therapy: analysis of prostate cancer response#176951arXiv (OAI)
• Variation of the relative biological effectiveness with fractionation in proton therapy: analysis of prostate cancer response#177205arXiv (OAI Expanded)
• Variation of the relative biological effectiveness with fractionation in proton therapy: analysis of prostate cancer response#177685arXiv
• Therapy-associated mutagenesis at CTCF binding sites is shaped by chromatin context and DNA repair capacity#192314bioRxiv / medRxiv
• Tumour-infiltrating lymphocyte therapy in melanoma: ready for prime time?#196263Springer Nature OA
• Data Management and Sharing Plan for: SBIR: In vivo engineering of B7-H3.CAR-T cells for ovarian cancer therapy#207837UNC Dataverse Dataverse OAI Archive
• Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma#226345ClinicalTrials.gov
• Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia#238167ClinicalTrials.gov
• Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma#249615ClinicalTrials.gov
• Development and verification of a prognostic nomogram model for triple-negative breast cancer patients with neoadjuvant therapy.#275626NCBI PubMed Central
• Integrative proteomics and metabolomics advance early cancer detection and targeted therapy with emerging technologies and clinical applications.#288854NCBI PubMed Central
• Ultrasound and Clinicopathological Features-Based Machine Learning Model for Predicting Neoadjuvant Therapy Efficacy in Breast Cancer.#292219NCBI PubMed Central
• A rationale for surgical debulking to improve anti-PD1 therapy outcome in non small cell lung cancer#308334HAL (France)
• Exploration of the Dynamic Changes and Mechanisms of the Immune Microenvironment in Advanced Colorectal Cancer Treated With IBI363 Combination Therapy#332752ClinicalTrials.gov
• Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy#332755ClinicalTrials.gov
• Recombinant adeno-associated virus-mediated HSV-TK/GCV gene therapy for ovarian cancer: an experimental study.#368183NCBI PubMed Central
• Guanylyl Cyclase 2C-Targeted Chimeric Antigen Receptor T-Cell Therapy in Patients With Metastatic Colorectal Cancer.#380992NCBI PubMed Central
• Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors#383549ClinicalTrials.gov
• Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma#407776ClinicalTrials.gov
• Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)#432888ClinicalTrials.gov
• AS1411-functionalized albumin nanoparticles for nucleolin-targeted realgar delivery and therapy in triple-negative breast cancer.#452941NCBI PubMed Central
• Integrated system for interstitial photodynamic therapy#612901Lund University Publications
• Structure and function of RET in multiple endocrine neoplasia type 2#646691Repisalud
• AI-assisted design and virtual profiling of targeted degraders for pancreatic cancer therapy via PROTAC technology.#685590NCBI PubMed Central
• A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy#424196ClinicalTrials.gov
• Modulating the gut microbiota to enhance immune checkpoint inhibitor efficacy in colorectal cancer: mechanisms, therapeutic strategies, and clinical perspectives#120190Europe PMC
• ERα-Independent Activity of Tamoxifen-Based Transition Metal Hybrids in Triple-Negative Breast Cancer Models In Vitro and In Vivo#241989IBISS
• Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial#298593IRIS
• Longitudinal changes in laboratory parameters and QTc during isavuconazole therapy in Japanese patients with hematologic malignancies#412835PLOS
• The New Era of Intraperitoneal Carboplatin in Ovarian Cancer: From Biological Rationale to Clinical Implementation#465457OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer#623546ClinicalTrials.gov